CTRI/2019/03/018181已完成4 期
A Prospective, Open-Label, Single Arm, Non-Comparative Study to Evaluate the Effectiveness and Safety of Thyroxine Sodium in Indian Patients with Primary Hypothyroidism
Dr Faraz Farishta0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Treatment naïve patients newly diagnosed with primary hypothyroidism
- •2. Patient with TSH level >10 mIU/L
- •3. Patients with fT4 level < 0.8 ng/dl
- •4. Patients willing to participate in the study, sign the Informed Consent Form (ICF) and ready to comply with protocol requirements
排除标准
- •1. Patients with primary hypothyroidism who are already on treatment with thyroxine for more than a month
- •2. Pregnant and/or lactating women
- •3. Patients with any acute or chronic cardiac or any other systemic illness that in the opinion of the investigator does not justify the patientâ??s inclusion in the study
研究者
相似试验
尚未招募
4 期
A Clinical study evaluating safety, tolerability, and efficacy of Liothyronine tablets in the patients suffering from thyroid gland hormone deficiency.CTRI/2023/04/051818Acme Generics Pvt. Ltd.
已完成
1 期
A Clinical Study To Evaluate Safety and Immunogenicity Of Pneumococcal Vaccine of Panacea Biotec In Healthy Toddlers.CTRI/2019/04/018677Panacea Biotec Limited30
尚未招募
2 期
A Clinical trial on pathiri ver chooranam in the management of madhumega noi (Diabetes mellitus) among patients attending OPD and IPD of Government Siddha Medical College and Hospital,PalayamkottaiCTRI/2024/05/068174Government Siddha medical college and Hospital
进行中（未招募）
1 期
A clinical trial to study the effects of selexipag on the heart in patients with Pulmonary Arterial HypertensioMedDRA version: 21.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2019-004783-22-FRACTELION Pharmaceuticals Ltd.80
已完成
4 期
A Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 Study of the Effects of Selexipag on Right Ventricular Remodeling in Pulmonary Arterial Hypertension Assessed by Cardiac Magnetic Resonance Imaging. (RESTORE)pulmonary arterial hypertensionPAHNL-OMON52455Actelion Pharmaceuticals5